ICD-10-CM Billable Code

D02.0

Carcinoma in situ of larynx

Clinical Classification Guidelines

Inclusion Terms

  • Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
  • Carcinoma in situ of epiglottis (suprahyoid portion)

Excludes Type 1

  • carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
  • carcinoma in situ of hypopharyngeal aspect (D00.08)
  • carcinoma in situ of marginal zone (D00.08)

Medical Intelligence & Overview

Carcinoma in situ of the larynx is a precancerous condition where abnormal cells are found in the lining of the larynx, but have not yet invaded deeper tissues. This stage is crucial for early intervention and treatment, as it offers a potential to prevent progression to invasive cancer. The condition specifically involves areas such as the epiglottis, aryepiglottic fold, and interarytenoid fold, particularly in the laryngeal aspect.

Causes & Symptoms

Clinical Causes: Tobacco smoking Heavy alcohol consumption Long-term exposure to environmental irritants or pollutants Chronic laryngeal inflammation Human papillomavirus (HPV) infection History of laryngeal or head and neck cancers Genetic predisposition

Key Symptoms: Persistent hoarseness or voice changes Sore throat that does not resolve Feeling of a lump or foreign body in the throat Difficulty swallowing or discomfort while swallowing Chronic cough Difficulty breathing in advanced cases Unexplained weight loss (less common in early stages)

Diagnostic & Treatment

Diagnosis Path: Diagnosis usually involves a thorough clinical examination, including laryngoscopy to visualize the larynx. A biopsy is essential to confirm carcinoma in situ, where abnormal, precancerous cells are identified without invasion into deeper tissues. Imaging studies like CT or MRI may be used to assess the extent of the lesion and rule out invasion or spread to adjacent structures.

Treatment Protocols: Management of carcinoma in situ of the larynx aims to eliminate abnormal cells and preserve laryngeal function. Treatment options include: - **Endoscopic Surgical Removal**: Physical removal of affected tissue via laryngoscopy - **Laser Surgery**: Precise laser excision to target abnormal cells while sparing healthy tissue - **Radiation Therapy**: Used in cases where surgery isn't feasible or as adjunct therapy - **Close Follow-up and Surveillance**: Regular examinations to monitor for recurrence or progression The choice of treatment depends on the lesion's size, location, patient health, and preferences. Early detection and management are crucial to prevent progression to invasive carcinoma.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D02.0 a billable ICD-10 code?
Yes, D02.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D02.0?
Clinical documentation must specify the nature of Carcinoma in situ of larynx and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

larynx carcinoma